Nexalin Technology (NXL) Cash from Financing Activities (2021 - 2026)

Nexalin Technology's (NXL) quarterly Cash from Financing Activities came in at $756421.0 in Q1 2026, up 44.48% quarter-over-quarter from $523550.0 in Q4 2025.

Nexalin Technology (NXL) Cash from Financing Activities (2021 - 2026) Analysis & Trends

Nexalin Technology's Cash from Financing Activities history runs 5 years deep, the most recent figure standing at $756421.0 for Q1 2026.

  • On a quarterly basis, Cash from Financing Activities changed N/A year-over-year to $756421.0 in Q1 2026; TTM through Mar 2026 was $1.3 million, a N/A change from a year earlier, with the FY2025 full-year figure at $5.2 million, up 14.48% from the prior year.
  • Cash from Financing Activities rose to $756421.0 in Q1 2026 per NXL's latest filing, from $523550.0 in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $8.5 million in Q3 2022 and bottomed at -$200000.0 in Q1 2023.
  • The 4-year median for Cash from Financing Activities is $261825.0 (2022), against an average of $1.6 million.
  • Biggest YoY gain for Cash from Financing Activities was 200100.0% in 2023; the steepest drop was 200100.0% in 2023.
  • Year by year, Cash from Financing Activities stood at $8.5 million in 2022, then tumbled by 102.35% to -$200000.0 in 2023, then surged by 361.78% to $523550.0 in 2025, then soared by 44.48% to $756421.0 in 2026.
  • Per Business Quant, the three latest NXL Cash from Financing Activities figures stand at $756421.0 (Q1 2026), $523550.0 (Q4 2025), and -$200000.0 (Q1 2023).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Abbott Laboratories 181.39 Bn 174.10 Bn 6.27 Bn 17.31 Bn
2 Stryker 128.38 Bn 125.50 Bn 3.81 Bn -1.51 Bn
3 Medtronic 107.68 Bn 98.46 Bn 6.41 Bn -888.00 Mn
4 Boston Scientific 67.98 Bn 66.53 Bn 3.61 Bn -260.00 Mn
5 Edwards Lifesciences 47.81 Bn 44.13 Bn 1.29 Bn -451.20 Mn
6 GE HealthCare Technologies 28.53 Bn 26.25 Bn 1.98 Bn 21.00 Mn
7 Dexcom 28.35 Bn 27.24 Bn 750.30 Mn -25.00 Mn
8 Smith & Nephew 26.78 Bn 26.20 Bn - -
9 Koninklijke Philips 25.34 Bn 22.21 Bn 2.07 Bn -26.93 Mn
10 Nexalin Technology 9.52 Mn 6.81 Mn 13,133.00 756,421.00

Historic Data

Download Data
DateValue
Mar 31, 2026 756,421.00
Mar 31, 2026 756,421.00
Dec 31, 2025 523,550.00
Dec 31, 2025 523,550.00
Mar 31, 2023 -200,000.00
Mar 31, 2023 -200,000.00
Sep 30, 2022 8.52 Mn
Sep 30, 2022 8.52 Mn
Jun 30, 2022 -5,000.00
Jun 30, 2022 -5,000.00
Mar 31, 2022 100.00
Mar 31, 2022 100.00
Dec 31, 2021 934,443.00
Dec 31, 2021 934,443.00